Literature DB >> 27685162

Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens.

Swinburne A J Augustine1, Tarsha N Eason2, Kaneatra J Simmons3, Clarissa L Curioso4, Shannon M Griffin3, Malini K D Ramudit3, Trevor R Plunkett5.   

Abstract

The etiology and impacts of human exposure to environmental pathogens are of major concern worldwide and, thus, the ability to assess exposure and infections using cost effective, high-throughput approaches would be indispensable. This manuscript describes the development and analysis of a bead-based multiplex immunoassay capable of measuring the presence of antibodies in human saliva to multiple pathogens simultaneously. Saliva is particularly attractive in this application because it is noninvasive, cheaper and easier to collect than serum. Antigens from environmental pathogens were coupled to carboxylated microspheres (beads) and used to measure antibodies in very small volumes of human saliva samples using a bead-based, solution-phase assay. Beads were coupled with antigens from Campylobacter jejuni, Helicobacter pylori, Toxoplasma gondii, noroviruses (G I.1 and G II.4) and hepatitis A virus. To ensure that the antigens were sufficiently coupled to the beads, coupling was confirmed using species-specific, animal-derived primary capture antibodies, followed by incubation with biotinylated anti-species secondary detection antibodies and streptavidin-R-phycoerythrin reporter (SAPE). As a control to measure non-specific binding, one bead set was treated identically to the others except it was not coupled to any antigen. The antigen-coupled and control beads were then incubated with prospectively-collected human saliva samples, measured on a high throughput analyzer based on the principles of flow cytometry, and the presence of antibodies to each antigen was measured in Median Fluorescence Intensity units (MFI). This multiplex immunoassay has a number of advantages, including more data with less sample; reduced costs and labor; and the ability to customize the assay to many targets of interest. Results indicate that the salivary multiplex immunoassay may be capable of identifying previous exposures and infections, which can be especially useful in surveillance studies involving large human populations.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685162      PMCID: PMC5092007          DOI: 10.3791/54415

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  27 in total

1.  Diagnosis of invasive amebiasis by enzyme-linked immunosorbent assay of saliva to detect amebic lectin antigen and anti-lectin immunoglobulin G antibodies.

Authors:  M D Abd-Alla; T F Jackson; S Reddy; J I Ravdin
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  A dynamic model to assess microbial health risks associated with beneficial uses of biosolids.

Authors:  Joseph N S Eisenberg; Jeffrey A Soller; James Scott; Don M Eisenberg; John M Colford
Journal:  Risk Anal       Date:  2004-02       Impact factor: 4.000

3.  Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.

Authors:  Andrew L Baughman; Kristine M Bisgard; Kathryn M Edwards; Dalya Guris; Michael D Decker; Kathy Holland; Bruce D Meade; Freyja Lynn
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

4.  Measles serological survey in the Italian population: interpretation of results using mixture model.

Authors:  Maria Cristina Rota; Marco Massari; Giovanni Gabutti; Marcello Guido; Antonella De Donno; Marta Luisa Ciofi degli Atti
Journal:  Vaccine       Date:  2008-06-27       Impact factor: 3.641

5.  Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection.

Authors:  L D Ballam; M A Mendall; M Asante; J Morris; D P Strachan; P H Whincup; D G Cook
Journal:  J Clin Pathol       Date:  2000-04       Impact factor: 3.411

6.  Microbead-based immunoassay for simultaneous detection of Shiga toxins and isolation of Escherichia coli O157 in foods.

Authors:  Laurie M Clotilde; Clay Bernard; Gary L Hartman; David K Lau; J Mark Carter
Journal:  J Food Prot       Date:  2011-03       Impact factor: 2.077

7.  Diagnosis of norwalk virus infection by indirect enzyme immunoassay detection of salivary antibodies to recombinant norwalk virus antigen.

Authors:  Christine L Moe; Arnie Sair; Lisa Lindesmith; Mary K Estes; Lee-Ann Jaykus
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

8.  Application of salivary antibody immunoassays for the detection of incident infections with Norwalk virus in a group of volunteers.

Authors:  Shannon M Griffin; Reagan R Converse; Juan S Leon; Timothy J Wade; Xi Jiang; Christine L Moe; Andrey I Egorov
Journal:  J Immunol Methods       Date:  2015-05-15       Impact factor: 2.303

9.  Antibody reactivity to Cryptosporidium parvum in saliva of calves after experimental infection.

Authors:  A Toyoguchi; Y Omata; T Koyama; T Kamiyoshi; K Takeda; H Furuoka; Y Kobayashi; F Kakuda; R Maeda; T Matsui; A Saito; T Mikami
Journal:  J Vet Med Sci       Date:  2000-11       Impact factor: 1.267

Review 10.  Current diagnostic uses of saliva.

Authors:  D B Ferguson
Journal:  J Dent Res       Date:  1987-02       Impact factor: 6.116

View more
  8 in total

1.  Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study.

Authors:  Victoria Leclercq; Nayema Van den Houte; Lydia Gisle; Inge Roukaerts; Cyril Barbezange; Isabelle Desombere; Els Duysburgh; Johan Van der Heyden
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

Review 2.  Potable Water Reuse: What Are the Microbiological Risks?

Authors:  Sharon P Nappier; Jeffrey A Soller; Sorina E Eftim
Journal:  Curr Environ Health Rep       Date:  2018-06

3.  Rapid Salivary IgG Antibody Screening for Hepatitis A.

Authors:  Swinburne A J Augustine; Tarsha N Eason; Kaneatra J Simmons; Shannon M Griffin; Clarissa L Curioso; Malini K D Ramudit; Elizabeth A Sams; Kevin H Oshima; Alfred Dufour; Timothy J Wade
Journal:  J Clin Microbiol       Date:  2020-09-22       Impact factor: 5.948

4.  Application of a salivary immunoassay in a prospective community study of waterborne infections.

Authors:  Andrey I Egorov; Shannon M Griffin; Honorine D Ward; Kevin Reilly; G Shay Fout; Timothy J Wade
Journal:  Water Res       Date:  2018-05-23       Impact factor: 11.236

5.  Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay.

Authors:  Swinburne A J Augustine; Kaneatra J Simmons; Tarsha N Eason; Clarissa L Curioso; Shannon M Griffin; Timothy J Wade; Alfred Dufour; G Shay Fout; Ann C Grimm; Kevin H Oshima; Elizabeth A Sams; Mary Jean See; Larry J Wymer
Journal:  Front Public Health       Date:  2017-05-01

6.  Visitors to a Tropical Marine Beach Show Evidence of Immunoconversions to Multiple Waterborne Pathogens.

Authors:  Kaneatra J Simmons; Tarsha N Eason; Clarissa L Curioso; Shannon M Griffin; Malini K D Ramudit; Kevin H Oshima; Elizabeth A Sams; Timothy J Wade; Ann Grimm; Alfred Dufour; Swinburne A J Augustine
Journal:  Front Public Health       Date:  2019-08-19

7.  Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen.

Authors:  Henri Garrison-Desany; Benard Omondi Ochieng; Maurice R Odiere; Helen Kuo; Dustin G Gibson; Joyce Were; E Wangeci Kagucia; Marcela F Pasetti; Hani Kim; Mardi Reymann; Katherine O'Brien; Kyla Hayford
Journal:  Vaccine       Date:  2020-11-27       Impact factor: 3.641

8.  Salivary Antibodies against Multiple Environmental Pathogens Found in Individuals Recreating at an Iowa Beach.

Authors:  Swinburne A J Augustine; Tarsha N Eason; Tim Wade; Shannon M Griffin; Elizabeth Sams; Kaneatra Simmons; Malini Ramudit; Kevin Oshima; Alfred Dufour
Journal:  Int J Environ Res Public Health       Date:  2021-05-28       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.